Meet Biovica at the World CDx Summit in Boston

Biovica will attend the 7th World Companion Diagnostic in Boston, October 18-21. The focus of the meeting is aligned with Biovicas strategy to rapidly progress exploratory biomarkers to registration, align clinical co-development and ensure reimbursement and market access success for precision therapies and assays.

“At the World CDx meeting we look forward to meet partners and to expand our collaborations with pharma companies interested in our DiviTum technology, embracing efficacy biomarkers. Our ambition is to provide our partners access to our unique serum thymidine kinase assay to predict and evaluate drug efficacy of new cancer drugs so that patients can get the best possible treatment.” – Ted Suh, Senior Director, US Business Development


If you are attending the summit and want to meet – let us know:

2017-01-03T10:42:56+00:00 September 28th, 2016 09:31|News|